Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 4Completed 4Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Polycythemia Vera 2Thrombosis 1Thrombocytosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia 1Myeloproliferative Disorders 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hodgkin Disease 1Glioma 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Bites and Stings 1Adenocarcinoma Of Esophagus 1

Interventions

Imatinib Mesylate 11Cyclophosphamide 11Peripheral Blood Stem Cell Transplantation 9Cyclosporine 8fludarabine phosphate 7Radiotherapy 7Methotrexate 7Filgrastim 7Dasatinib 7Busulfan 7Antilymphocyte Serum 7nilotinib 6Tacrolimus 6Mycophenolic Acid 6Sirolimus 5Cord Blood Stem Cell Transplantation 5bosutinib 4Whole-Body Irradiation 4Methylprednisolone 4Melphalan 4Interferon-alpha 4ponatinib 3Alemtuzumab 3sargramostim 2Sunitinib 2Rituximab 2Moxifloxacin 2Leucovorin 2Homoharringtonine 2Granulocyte Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myeloid, Chronic-Phase × Hydroxyurea × Clear all
NCT00004933 2016-07-04

Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

Alliance for Clinical Trials in Oncology

Phase 3 Terminated
5 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡